AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. ACN
7. AZN
8. ROIV
9. AAPL
10. HOOD

Go back to AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
AbbVie (NYSE: ABBV) Delayed: 248.78 -7.68 (2.99%)
Previous Close $256.46    52 Week High $68.12 
Open $251.84    52 Week Low $50.71 
Day High $254.62    P/E 53.97 
Day Low $248.41    EPS $4.61 
Volume 5,569,859